fbpx 54033-001: Assessing Implementation Barriers and Program Options for Elimination of Hepatitis C | Asian Development Bank

Pakistan: Assessing Implementation Barriers and Program Options for Elimination of Hepatitis C

Sovereign (Public) Project | 54033-001 Status: Active

The TA will be aligned with the following impact: helping Pakistan assess and develop national and provincial testing and treatment plans for HCV and identifying barriers and bottlenecks for implementation of the National Hepatitis Strategic Framework . The TA will support recruitment of experts to help with establishing the program for HCV.

Project Details

Project Officer
Wong, Cebele Central and West Asia Department Request for information
Country
  • Pakistan
Sector
  • Health
 
Project Name Assessing Implementation Barriers and Program Options for Elimination of Hepatitis C
Project Number 54033-001
Country Pakistan
Project Status Active
Project Type / Modality of Assistance Technical Assistance
Source of Funding / Amount
TA 9952-PAK: Assessing Implementation Barriers and Program Options in Halting the Hepatitis C Epidemic
Technical Assistance Special Fund US$ 200,000.00
Strategic Agendas Inclusive economic growth
Drivers of Change Gender Equity and Mainstreaming
Governance and capacity development
Knowledge solutions
Sector / Subsector

Health / Health sector development and reform

Gender Equity and Mainstreaming Some gender elements
Description The TA will be aligned with the following impact: helping Pakistan assess and develop national and provincial testing and treatment plans for HCV and identifying barriers and bottlenecks for implementation of the National Hepatitis Strategic Framework . The TA will support recruitment of experts to help with establishing the program for HCV.
Project Rationale and Linkage to Country/Regional Strategy Pakistan has one of the highest Hepatitis C Virus (HCV) prevalence rates in the world, with an estimated 5% of the population living with the infection. If left untreated, HCV infection will lead to chronic liver disease, cirrhosis and/or liver cancer in one third of infected persons. Modalities of HCV transmission in Pakistan are well established, and efforts are being made to improve prevention through infection prevention and control programs in hospitals, blood screening, educating private health care providers and shop owners , and prevention of transmission within the family. However, these prevention measures often involve behavioral change and will take time to have a substantial impact on HCV transmission, morbidity and mortality- as a result at great cost to the economy of Pakistan. Treatment and cure, which is achieved after a three-month course of medication, on the other hand, can quickly reduce the pool of infected persons and thereby reduce transmission, to a point that the epidemic is no longer self-sustaining. Treatment has greatly improved with the development of new highly effective direct-acting antivirals (DAAs) which can be procured by the government at costs as low as $60 per chronically infected person, making mass treatment within reach. National and provincial programs for HCV prevention and control have been in place since 2005, but they are not coordinated nationally and have not been scaled up to serve the population en masse. HCV screening has improved with a simple and cost-effective test that can be done in any health facility. The HCV epidemic is a large-scale but neglected national health emergency. The proposed program for HCV testing and treatment presents a unique opportunity to obtain lasting health impact for the general public, reach out to rural women, sustain impact by contributing to interruption of transmission and promotion of behavioral change, strengthen health services, which will result in major social and economic benefits.
Impact Viral hepatitis as a major public health threat eliminated by 2030 (National Hepatitis Strategic Framework [NHSF] for Pakistan 2017 2021).
Project Outcome
Description of Outcome Capacity of the MONHSRC to design a national HCV screening and treatment program strengthened.
Progress Toward Outcome
Implementation Progress
Description of Project Outputs HCV program implementation barriers and options assessed.
Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation
Responsible ADB Officer Wong, Cebele
Responsible ADB Department Central and West Asia Department
Responsible ADB Division CWSS
Executing Agencies
Asian Development Bank
6 ADB Avenue,
Mandaluyong City 1550, Philippines
Ministry of Health
Room No. 119, Block C
Pakistan Secretariat
Islamabad, Pakistan
Timetable
Concept Clearance -
Fact Finding 23 Jan 2020 to 23 Jan 2020
MRM -
Approval 02 Mar 2020
Last Review Mission -
Last PDS Update 02 Mar 2020

TA 9952-PAK

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
02 Mar 2020 - 02 Mar 2020 31 Dec 2020 - -
Financing Plan/TA Utilization Cumulative Disbursements
ADB Cofinancing Counterpart Total Date Amount
Gov Beneficiaries Project Sponsor Others
200,000.00 0.00 0.00 0.00 0.00 0.00 200,000.00 02 Mar 2020 0.00

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.

None currently available.

Safeguard Documents See also: Safeguards

Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.

Evaluation Documents See also: Independent Evaluation

None currently available.

Related Publications

None currently available.


The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

Tender Title Type Status Posting Date Deadline
Public Health Specialist Individual - Consulting Active 11 Mar 2020 14 Apr 2020
Health System Research and Policy Support Firm Firm - Consulting Closed 11 Mar 2020 25 Mar 2020

Contracts Awarded

No contracts awarded for this project were found

Procurement Plan

None currently available.